SEC Form D · Amendment · filed August 11, 2022
Centrexion Therapeutics Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
J. C. Lopez, M.D · BOSTON, MADirectorJoseph R. Swedish · BOSTON, MADirectorJames N. Campbell, M.D · BOSTON, MAExec · DirectorShawn R. Tomasello · BOSTON, MADirectorPeter R. Wirth · Boston, MADirectorMichael J. Ward · BOSTON, MAExecColin J. Hill · BOSTON, MADirectorRandall M. Stevens · BOSTON, MAExecJeffrey B. Kindler · BOSTON, MAExec · DirectorDezhi J. Kang, Ph.D · BOSTON, MADirectorSol J. Barer · BOSTON, MADirectorSarah Robertson · Denver, CODirectorClyde D. Cady · Bay Village, OHExecBrian Bannister · Casper, WYDirectorErik Tuveson · Northborough, MADirectorJosh Phair · Casper, WYDirectorGary Bechtel · Bloomfield Hills, MIDirectorTom Mcgovern · Bloomfield Hills, MIExec · DirectorMark Hartig · Casper, WYExec · DirectorJeffry D. Elliott · Bay Village, OHExecBrook Scardina · Bloomfield Hills, MIDirectorRaymond Davis · Bloomfield Hills, MIDirectorTaylor Frankel · Teton Village, WYDirectorGabriel E. Felzenszwalb · Rio de Janeiro, GuernseyDirectorAlessandro Horta · Rio de Janeiro, GuernseyExec · DirectorBruno A. Sacchi Zaremba · Rio de Janeiro, GuernseyDirectorCarlos E. Martins E Silva · Rio de Janeiro, GuernseyExecCindy W. Kim · Seattle, WAExecRobert Monk · Reston, VAExec · DirectorKevin Cunningham · Reston, VADirectorEugene Park · Reston, VADirectorDarragh J. Murphy · Camana Bay, Grand Cayman, Cayman IslandsDirectorHartej Jagdev · Grand Cayman, Cayman IslandsDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗